Alterity Therapeutics Limited - Depositary Receipt (Common Stock) logo

Alterity Therapeutics Limited - Depositary Receipt (Common Stock) (ATHE)

Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
4. 67
+0.12
+2.7533%
$
41.15M Market Cap
- P/E Ratio
- Div Yield
4,031 Volume
0 Eps
$ 4.54
Previous Close
Add Transaction
Day Range
4.54 4.75
Year Range
2.66 6.03
Want to track ATHE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Alterity Therapeutics Limited - Depositary Receipt (Common Stock) (ATHE) Statistics

Valuation metrics

Market Cap 41.15M
Enterprise value 72.77M
Trailing P/E (ttm) -6.83
Forward P/E -
PEG ratio -0.1
Price/Sales (ttm) 31.78
Price/Book (mrq) 2.1
Enterprise Value/Revenue 18.98
Enterprise Value/EBITDA -3.62

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 17.55K
Average volume (90 days) 82.58K

Price summary

52-Week low 2.66
52-Week high 6.03
Beta -
50-Day moving average 4.47
200-Day moving average 3.79

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 9 Jan 2023

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -3.81%
Operating margin -5.26%

Operational effectiveness

Return on assets -0.26%
Return on equity -0.3%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 11.3
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -43
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 145
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 21.98%
Book value per share (mrq) 159.93

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -